WILMINGTON, Mass., Oct. 4 /PRNewswire-FirstCall/ -- CardioTech International, Inc. , a developer and manufacturer of advanced medical device products for the treatment of cardiovascular and other diseases, today announced that it will be conducting a tour of its facilities after the formal proceedings of its annual shareholders meeting on October 11 at 10 a.m. (EDT). The annual meeting will be held at CardioTech headquarters, 229 Andover Street, Wilmington, MA.
About CardioTech International:
CardioTech International, Inc. is a medical device company that designs, develops, manufactures and sells innovative products for the treatment of cardiovascular, orthopedic, oncological and other diseases. The Company provides its customers access to a range of proprietary and novel polymer and surface modification technologies. CardioPass(TM) is CardioTech's proprietary, synthetic coronary artery bypass graft. (SynCAB) The Company generates revenues from sales of advanced medical devices, as well as from contracted product design and development services. More information about CardioTech is available at its website: http://www.cardiotech-inc.com.
For Further Information Contact: Eric Walters Vice President & Chief Financial Officer CardioTech International, Inc. 978-657-0075 general-info@cardiotech-inc.com Sylvia Dresner Senior Vice President VMW Corporate & Investor Relations 212-616-6161 info@vmwcom.com
CardioTech InternationalCONTACT: Eric Walters, Vice President & Chief Financial Officer ofCardioTech International, Inc., +1-978-657-0075,general-info@cardiotech-inc.com; or Sylvia Dresner, Senior Vice Presidentof VMW Corporate & Investor Relations, +1-212-616-6161, info@vmwcom.com
Web site: http://www.cardiotech-inc.com/
